| Current Price | $1.35 | Mkt Cap | $24.2M |
|---|---|---|---|
| Open | $1.46 | P/E Ratio | 0.00 |
| Prev. Close | $1.35 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.28 - $1.54 | Volume | 221,465 |
| 52-Wk Range | $0.50 - $33.25 | Avg. Daily Vol. | 274,090 |
| Current Price | $1.35 | Mkt Cap | $24.2M |
|---|---|---|---|
| Open | $1.46 | P/E Ratio | 0.00 |
| Prev. Close | $1.35 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.28 - $1.54 | Volume | 221,465 |
| 52-Wk Range | $0.50 - $33.25 | Avg. Daily Vol. | 274,090 |
The best Bull and Bear pitches based on recency and number of recommendations.
1. Recent regulatory changes to accelerate regenerative medicine use in Japan, will allow faster development of their products. CEO has already made several trips so as to get his ducks in a row.2.Second quarter results on phase II study on… More
The most unrealistic thing I've ever seen in a movie is when an entire family sits down to eat breakfast together on a weekday.
Read the most recent pitches from players about ATHX.
Recs
naysaySA
(71.88)
Submitted: 6/18/2020 8:26:04 PM :
Start Price:
$2.84
NASDAQ:ATHX Score:
+79.87
Chosen by Seeking Alpha author .Croatoan Capital as a long. Therefore, I short.
Recs
Recs
zzlangerhans
(99.73)
Submitted: 2/3/2016 3:56:25 PM :
Start Price:
$1.28
NASDAQ:ATHX Score:
+101.84
Nothing new from my last red thumb except an inexplicable price rebound despite a crashing sector, so I'll repost my last pitch.
I just wasted close to an hour trying to translate pages of handwaving from the last Athersys conference call into actionable information. My takeaway: I'm supposed to ignore all the negative developments over the last few years with MultiStem because cytokines. Add this to the company's recent Enjo Kosai activities with various small Japanese pharmas and we have a market cap of 104M, cash of about 40M (inclusive of Healios upfront payment), and a probable inert stem cell soup therapy. Athersys share price is holding up while former darlings StemCells, Caladrius, and Pluristem are going down the toilet but don't expect that to last long as spec biotech remains volatile and new positive catalysts fail to appear during the year.
Find the members with the highest scoring picks in ATHX.
drugtrader (55.94) Score: +346.48
The Score Leader is the player with the highest score across all their picks in ATHX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Billdo2211 | 28.92 | 12/8/2011 |
|
3M | $2.24 | -38.50% | +215.69% | +254.20 | 0 Comment | |
| kevrose31 | 79.04 | 1/10/2014 |
|
1Y | $4.08 | -66.24% | +114.92% | +181.15 | 0 Comment | |
| MFBurritoSquat | 55.48 | 1/17/2013 |
|
3M | $1.24 | +11.00% | +167.81% | +156.81 | 0 Comment | |
| IdahoInvestor | 27.60 | 10/23/2012 |
|
5Y | $1.06 | +29.95% | +179.08% | +149.12 | 0 Comment | |
| MMCapitalMgmt | 99.96 | 4/14/2016 |
|
5Y | $2.49 | -44.68% | +90.06% | +134.74 | 0 Comment | |
| RafaelStock | 97.27 | 8/1/2016 |
|
5Y | $2.23 | -38.23% | +82.02% | +120.25 | 0 Comment | |
| zzlangerhans | 99.73 | 2/3/2016 |
|
1Y | $1.28 | +7.79% | +109.62% | +101.84 | 1 Comment | |
| RunandHide | < 20 | 4/28/2014 |
|
5Y | $1.19 | +16.24% | +112.38% | +96.14 | 0 Comment | |
| LifeScientist | 28.81 | 1/11/2016 |
|
3M | $1.23 | +12.45% | +107.20% | +94.75 | 1 Comment | |
| NuclearSteve | 50.73 | 4/24/2015 |
|
5Y | $1.29 | +6.78% | +86.89% | +80.11 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
